Mayne turns to Takeovers Panel in latest move to salvage $672M Cosette deal

M&A 2025-11-07 11:13 pm By Cat Fredenburgh

Please login to bookmark

Mayne Pharma is not walking away from US drug maker Cosette’s proposed takeover without a fight, filing an application with the Takeovers Panel to force Cosette to agree to the conditions needed to win FIRB approval for the $672 million deal.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au